TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Participants Who Agreed to Take a COVID-19 Rapid Test of Those Enrolled
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mean Number of COVID-19 Rapid Tests Taken
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Uptake of the Recruitment Strategy Into the Community
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reach of the Recruitment Strategy Into the Community
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Peak plasma drug concentration of antineoplastic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Random plasma drug concentration of antineoplastic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trough plasma drug concentration of antineoplastic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite Safety Success Rate
Endpoint domain: Adverse events/effects
Primary endpoint: Modified Mayo Wrist Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle strength measure by hand grip strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family Dermatology Life Quality Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cognitive Emotion Regulation Questionnaire - Short Version
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Short Version of the Cognitive Emotion Regulation Questionnaire for Spanish Kids
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diagnosis of cerebrovascular complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: uveitis progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute change in PEC total score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal Ideation & Behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Social Attention
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Peer interest
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rates of focal child communication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of reciprocal child-peer exchanges
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient anxiety about anesthesia and surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Active Knee Extension Test (AKET)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Modified Schobber's Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Maximum Toxicity Dose (MTD)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Salivary Immunoglobulin A (SIgA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Salivary cortisol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in General Health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Forced expiratory volume in 1 second/Forced vital capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Synchronisation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conversion from negative to positive COVID-19 test
Endpoint domain: Adverse events/effects
Primary endpoint: Uptake of recommendations based on PGx
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sexual Victimization
Endpoint domain: Adverse events/effects
Primary endpoint: Procedural feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Image utilization feasibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vasoactive-Inotropic Score for duration of pressor need
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of laboratory abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of participants who achieve a response
Endpoint domain: Adverse events/effects
Primary endpoint: Quantitative analysis of PET brain scans
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transplant free survival mortality
Endpoint domain: Mortality/survival
Primary endpoint: State-Trait Anxiety Inventory (STAI FORM TX)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pregnancy Stress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Alcohol Impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Pocket Probing Depth (PPD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Usability of a health app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Qualitative perspective on chatbot app usage experience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mortality rate at day 0
Endpoint domain: Mortality/survival
Primary endpoint: mortality rate at day 3
Endpoint domain: Mortality/survival
Primary endpoint: Immunogenicity index 1-geometric Mean Concentration (GMC) for Serotype-specific Pneumococcal IgG Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Immunogenicity index 2-geometric Mean Concentration (GMC) for Serotype-specific Pneumococcal IgG Antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Live birth rate per randomized patient
Endpoint domain: Mortality/survival
Primary endpoint: Live birth rate per protocol
Endpoint domain: Mortality/survival
Primary endpoint: SARS-CoV-2 specific IgG antibody immune response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Physical activity behavior (step counts)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: βhCG levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Anti-Müllerian hormone levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Heart failure relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Student Satisfaction and Self-confidence in Learning
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in eye (saccade) movement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in head movement time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of Participants who Experience a Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Secondary transmission/prevalence of SARS-CoV-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Return to school outcomes
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Prenatal Distress Scale (PBL)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in the patient's palliative care needs
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Functional near-infrared spectroscopy (fNIRS assessment)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of 2-grade or more improvement on the Masseter Muscle Prominence Scale (MMPS) by Investigator
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of 2-grade or more improvement on the Masseter Muscle Prominence Scale - Participant (MMPS-P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Scoring intestinal inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of moderate to severe visceral pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Disorder Society-Unified Parkinson´s Disease Rating Scale (MDS-UPDRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spanish validated version of the Disability of the Arm, Shoulder and Hand (DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Referral to hospital
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Long term stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plate migration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Cognition knowledge scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Confidence scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Satisfied from learning
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical progression of Harris Hip Score (HHS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Consistency of PGT-M with prenatal diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of participants with at least 50% decrease in NRS-NP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Failure of a single surgical debridement
Endpoint domain: Adverse events/effects
Primary endpoint: Self-report Ratings of Knee Pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Whole-body distribution and dosimetry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of pharmacokinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of participants achieving clinical response according to the ACR 20 criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity engagement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: complete tumor response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Completion Rate of App-Delivered Content (Cohort C)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention Rate (Cohort C)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Retention Rate (Cohort D)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Rate of treatment-related Serious Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: sum of score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Presence of myoclonus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Gait/walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Device Assisted Therapy readiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Time Bradykinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percent Time Dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fall prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-motor outcomes
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Patient Reported Experience Measurements (PREMs)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Infant Motor Profile (IMP) scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum level of irisin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of subjects with serum uric acid level < 300 μmoL/L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Participants retention rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Participants participation rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diagnostic performance1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnostic performance2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients starting lymphodepletion on time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of Adverse Events [Safety and Tolerability]
Endpoint domain: Adverse events/effects
Primary endpoint: Ratio of SARS-CoV-2 sVNA titer against a relevant variant following VYD222 administration at Day 28
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tumor biomarker expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Beck Depression Inventory Second Edition
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Successful removal of endotracheal tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Upper limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Efficacy in treating Iron deficiency anemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Effectiveness of bone removal to access lesion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of myocardial perfusion reserve (MPR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of injection
Endpoint domain: Adverse events/effects
Primary endpoint: engagement
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Eczema Area and Severity Index (EASI) Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Peak Pruritus Numerical Rating Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Hematopoietic niche characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Systemic inflammation characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Medullary inflammation characterization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adipose tissue blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: F.n. loads in CRC tissues
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Ecological Momentary Assessment (EMA) of Stress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Euploid rate of blastocysts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission (CR) and complete remission with partial hematologic recovery (CRh) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hematologic outcomes
Primary endpoint: Incidence of Phantom Limb Pain
Endpoint domain: Adverse events/effects
Primary endpoint: High-resolution CT imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak % change of CBv from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first acute care visit
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Level of knowledge related to disaster nursing services
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Volunteer intention to become a disaster nurse
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Perception of self-efficacy related to disaster nursing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Completion of Patient-Reported Outcomes (PROs)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in percentage of heavy drinking days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate or severe COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Level of speechreading skill
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of performance in emotions (facial expressions)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance in sentence-level speechreading task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child Body Mass Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Intellectual function (WASI-II IQ)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Child insulin resistance (HOMA2-IR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: K-RBANS
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Lesion Epithelisation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: liver steatosis grade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Maximum Effect (Emax) for Drug Liking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Take Drug Again
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency and seriousness of adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Frequency and seriousness of adverse drug reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Past month high-intensity drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of diagnostic samples positive for malignant neoplasm or specific benign process
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Isokinetic Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Participants with HIV-1 RNA ≥50 copies/mL at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Participants with one or more AEs at Week 48
Endpoint domain: Adverse events/effects
Primary endpoint: Participants with an AE leading to discontinuation of study intervention at Week 48
Endpoint domain: Adverse events/effects
Primary endpoint: Number of patients failing to complete temozolomide (TMZ)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of requests for epidural anesthesia
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time taken for caries removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Child pain perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: All-cause mortality at 30 days after operation
Endpoint domain: Mortality/survival
Primary endpoint: Clinical repeatability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety Incidences
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical outcomes among COVID-19 patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with abnormal corrected calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with abnormal parathyroid hormone (PTH)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Proportion of patients with abnormal 24-hour urine calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Frequency and Severity of Unanticipated Adverse Device-related Events
Endpoint domain: Adverse events/effects
Primary endpoint: Esophageal variceal bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Post operative Swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trismus- Post surgical limitation in mouth opening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound/ extraction socket healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of repetitions performed at 65%1RM until task failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Drug Liking (Maximum Effect [Emax])
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Incontinence Consultation Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: International Incontinence Consultation Questionnaire - Male Lower Urinary Tract Symptoms (ICIQ-MLUTS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Identification of morphologic characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in transfusion patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in geriatric problem management
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status